Bio-Rad Laboratories has signed an agreement to acquire certain diagnostic businesses of Biotest for 45 million euros, the terms of which were not disclosed. The transaction is subject to closing conditions, including regulatory approvals, and is expected to close in the first quarter of 2010.
Biotest develops, manufactures and markets pharmaceutical, biotherapeutic and diagnostic products. Integrating Biotest’s diagnostic business into Bio-Rad’s product portfolio will broaden the company’s offering in the area of immunohematology and provide Bio-Rad access to the US markets with a full range of products.
Phone: 0011 1 510 724 7000
Alamar Biosciences NULISAseq Mouse Panel 120 for protein biomarker analysis
The multiplex panel encompasses a wide selection of proteins essential for studying key...
Azure Biosystems Ao Microplate Reader
The 96-well Ao Microplate Reader from Azure Biosystems offers a multitude of features to help...
Navinci Naveni Plex isPLA multiplex solution
The isPLA multiplex solution is designed to simultaneously detect PD1/PD-L1 interactions...
